Revision of Clinical Practice Guidelines for Pancreatic Cancer 2022 -stents-

Abstract

In the previous Clinical Practice Guideline 2019, Clinical Questions (CQ) included ①approach routes for biliary drainage for patients with unresectable pancreatic cancer (PC), ②preoperative biliary drainage for PC with obstructive jaundice, ③biliary drainage for unresectable PC with obstructive jaundice, and ④selection of treatment for unresectable PC with gastrointestinal obstruction. In this revision, we reviewed current clinical issues, including ⑤respond to acute pancreatitis and cholecystitis associated with biliary stents, ⑥respond to obstruction of self-expanding metallic stents (SEMS), ⑦methods of biliary drainage for PC with gastrointestinal obstruction and obstructive jaundice, and ⑧indications for SEMS for chemotherapy and radiotherapy for unresectable PC with obstructive jaundice. As a result of careful consideration and discussion, ⑦ and ⑧ were set as CQs, and ⑤ and ⑥ were designated as columns. The 2022 edition consists of six CQs and two columns.